Literature DB >> 23071339

Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros.

Fatih M Uckun1, Hong Ma, Jian Zhang, Zahide Ozer, Sinisa Dovat, Cheney Mao, Rita Ishkhanian, Patricia Goodman, Sanjive Qazi.   

Abstract

Ikaros is a zinc finger-containing DNA-binding protein that plays a pivotal role in immune homeostasis through transcriptional regulation of the earliest stages of lymphocyte ontogeny and differentiation. Functional deficiency of Ikaros has been implicated in the pathogenesis of acute lymphoblastic leukemia, the most common form of childhood cancer. Therefore, a stringent regulation of Ikaros activity is considered of paramount importance, but the operative molecular mechanisms responsible for its regulation remain largely unknown. Here we provide multifaceted genetic and biochemical evidence for a previously unknown function of spleen tyrosine kinase (SYK) as a partner and posttranslational regulator of Ikaros. We demonstrate that SYK phoshorylates Ikaros at unique C-terminal serine phosphorylation sites S358 and S361, thereby augmenting its nuclear localization and sequence-specific DNA binding activity. Mechanistically, we establish that SYK-induced Ikaros activation is essential for its nuclear localization and optimal transcription factor function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23071339      PMCID: PMC3497833          DOI: 10.1073/pnas.1209828109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates.

Authors:  Liang Xue; Wen-Horng Wang; Anton Iliuk; Lianghai Hu; Jacob A Galan; Shuai Yu; Michael Hans; Robert L Geahlen; W Andy Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

Review 2.  Ikaros in immune receptor signaling, lymphocyte differentiation, and function.

Authors:  Matthias Merkenschlager
Journal:  FEBS Lett       Date:  2010-10-02       Impact factor: 4.124

Review 3.  Ikaros, CK2 kinase, and the road to leukemia.

Authors:  Sinisa Dovat; Chunhua Song; Kimberly J Payne; Zhanjun Li
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

4.  Zinc finger structure-function in Ikaros Marvin A Payne.

Authors:  Marvin A Payne
Journal:  World J Biol Chem       Date:  2011-06-26

Review 5.  Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomas.

Authors:  Fatih M Uckun; Sanjive Qazi
Journal:  Expert Rev Anticancer Ther       Date:  2010-09       Impact factor: 4.512

6.  A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase.

Authors:  Shane Atwell; Jason M Adams; John Badger; Michelle D Buchanan; Ingeborg K Feil; Karen J Froning; Xia Gao; Jörg Hendle; Kevin Keegan; Barbara C Leon; Hans J Müller-Dieckmann; Vicki L Nienaber; Brian W Noland; Kai Post; K R Rajashankar; Aurora Ramos; Marijane Russell; Stephen K Burley; Sean G Buchanan
Journal:  J Biol Chem       Date:  2004-10-26       Impact factor: 5.157

7.  Syk is a dual-specificity kinase that self-regulates the signal output from the B-cell antigen receptor.

Authors:  Beate Heizmann; Michael Reth; Simona Infantino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-12       Impact factor: 11.205

Review 8.  The SYK tyrosine kinase: a crucial player in diverse biological functions.

Authors:  Attila Mócsai; Jürgen Ruland; Victor L J Tybulewicz
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

9.  Ikaros interacts with P-TEFb and cooperates with GATA-1 to enhance transcription elongation.

Authors:  Stefania Bottardi; Farah A Zmiri; Vincent Bourgoin; Julie Ross; Lionel Mavoungou; Eric Milot
Journal:  Nucleic Acids Res       Date:  2011-01-17       Impact factor: 16.971

10.  Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis.

Authors:  Jiangwen Zhang; Audrey F Jackson; Taku Naito; Marei Dose; John Seavitt; Feifei Liu; Elizabeth J Heller; Mariko Kashiwagi; Toshimi Yoshida; Fotini Gounari; Howard T Petrie; Katia Georgopoulos
Journal:  Nat Immunol       Date:  2011-11-13       Impact factor: 25.606

View more
  35 in total

1.  CD22ΔE12 as a molecular target for corrective repair using RNA trans-splicing: anti-leukemic activity of a rationally designed RNA trans-splicing molecule.

Authors:  Fatih M Uckun; Sanjive Qazi; Hong Ma; Gregory H Reaman; Lloyd G Mitchell
Journal:  Integr Biol (Camb)       Date:  2015-02       Impact factor: 2.192

Review 2.  Microfluidics: reframing biological enquiry.

Authors:  Todd A Duncombe; Augusto M Tentori; Amy E Herr
Journal:  Nat Rev Mol Cell Biol       Date:  2015-09       Impact factor: 94.444

3.  Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survival.

Authors:  Jasmin Corso; Kuan-Ting Pan; Roland Walter; Carmen Doebele; Sebastian Mohr; Hanibal Bohnenberger; Philipp Ströbel; Christof Lenz; Mikolaj Slabicki; Jennifer Hüllein; Federico Comoglio; Michael A Rieger; Thorsten Zenz; Jürgen Wienands; Michael Engelke; Hubert Serve; Henning Urlaub; Thomas Oellerich
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-06       Impact factor: 11.205

4.  Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia.

Authors:  Fatih M Uckun; Dorothea E Myers; Sanjive Qazi; Zahide Ozer; Rebecca Rose; Osmond J D'Cruz; Hong Ma
Journal:  J Clin Invest       Date:  2015-01-26       Impact factor: 14.808

Review 5.  Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.

Authors:  Mariya O Krisenko; Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2014-11-04

6.  Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia.

Authors:  Sanjive Qazi; Fatih M Uckun
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

7.  Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production.

Authors:  Shaun O'Brien; Rajan M Thomas; Gerald B Wertheim; Fuqin Zhang; Hao Shen; Andrew D Wells
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

8.  Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Authors:  Tawin Iempridee; Jessica A Reusch; Andrew Riching; Eric C Johannsen; Sinisa Dovat; Shannon C Kenney; Janet E Mertz
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK.

Authors:  Rossana Maffei; Stefania Fiorcari; Stefania Benatti; Claudio Giacinto Atene; Silvia Martinelli; Patrizia Zucchini; Leonardo Potenza; Mario Luppi; Roberto Marasca
Journal:  Leukemia       Date:  2021-02-23       Impact factor: 11.528

10.  The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma.

Authors:  Mohamed H S Awwad; Katharina Kriegsmann; Julian Plaumann; Michael Benn; Jens Hillengass; Marc S Raab; Uta Bertsch; Markus Munder; Katja Weisel; Hans Jürgen Salwender; Mathias Hänel; Roland Fenk; Jan Dürig; Carsten Müller-Tidow; Hartmut Goldschmidt; Michael Hundemer
Journal:  Oncoimmunology       Date:  2018-08-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.